Basel, Switzerland

Narendra Panday

This inventor holds 22 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 2003-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Narendra Panday. Retrieved from https://idiyas.com/inventor/narendra-panday

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 4.5


Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Basle, CH (2004)
  • Munich, DE (2009 - 2010)
  • Basel, CH (2003 - 2011)

Company Filing History:


Years Active: 2003-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
Tetrahydrocarbazoles
Hexafluoroisopropanol
Cyclic Amines
Heteroarylacetamide
Factor Xa Inhibitors
Benzimidazole
Pyrrolidine
Dicarboxamide
Indolyl Derivatives
Aminoalkylamide
Hydroxyalkylamide
Dihydroindole
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Narendra Panday in the Field of Pharmaceuticals

Introduction: Narendra Panday is a prolific inventor based in Basel, Switzerland, known for his significant contributions to the pharmaceutical industry. With a total of 22 patents to his name, his work focuses on developing novel compounds that aim to address various metabolic and inflammatory diseases.

Latest Patents: Among his latest innovations, Panday has developed patents for Tetrahydrocarbazoles and derivatives. This invention relates to specific compounds that can be utilized in the treatment and prevention of diseases modulated by LXRα and/or LXRβ agonists. These conditions include elevated lipid and cholesterol levels, particularly low HDL-cholesterol and high LDL-cholesterol, as well as atherosclerotic diseases, diabetes, and Alzheimer's disease, among others. Another notable invention is his work on Hexafluoroisopropanol derivatives, which are novel compounds that bind to LXR alpha and LXR beta, positioning them as potential medicaments.

Career Highlights: Narendra Panday's career spans several years in the pharmaceutical sector, primarily with Hoffmann-La Roche Inc., where he plays a crucial role in innovative drug development. His expertise in medicinal chemistry has led to the successful formulation of new therapeutic agents that hold promise for various health challenges.

Collaborations: Throughout his career, Panday has collaborated with notable scientists, including his coworkers Henrietta Dehmlow and Bernd Kuhn. These partnerships have fostered a rich environment for scientific inquiry and innovation, enhancing the potential for groundbreaking discoveries in their field.

Conclusion: Narendra Panday exemplifies the spirit of innovation in pharmaceuticals, with his extensive patent portfolio reflecting his commitment to improving health outcomes. His work not only contributes to academic research but also significantly impacts the lives of patients suffering from complex diseases, solidifying his reputation as a leading inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…